Litchfield Hills Research Weighs in on NextPlat Q2 Earnings

NextPlat Corp. (NASDAQ:NXPL) – Research analysts at Litchfield Hills Research boosted their Q2 2027 EPS estimates for NextPlat in a research report issued on Thursday, July 16th. Litchfield Hills Research analyst T. O’neill now expects that the company will earn $0.15 per share for the quarter, up from their previous estimate of $0.14. Litchfield Hills Research has a “Buy” rating and a $11.00 price objective on the stock. The consensus estimate for NextPlat’s current full-year earnings is ($0.55) per share. Litchfield Hills Research also issued estimates for NextPlat’s Q4 2027 earnings at $0.18 EPS and FY2027 earnings at $0.58 EPS.

NextPlat (NASDAQ:NXPL) last posted its earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share (EPS) for the quarter. The firm had revenue of $9.86 million during the quarter. NextPlat had a negative net margin of 23.14% and a negative return on equity of 58.05%.

NXPL has been the subject of several other research reports. Zacks Research raised shares of NextPlat to a “hold” rating in a report on Thursday, June 25th. Weiss Ratings raised shares of NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, NextPlat presently has an average rating of “Hold” and an average price target of $11.00.

NextPlat Stock Down 4.1%

NASDAQ NXPL opened at $5.81 on Friday. The firm has a market cap of $15.75 million, a PE ratio of -1.34 and a beta of 1.87. The stock’s 50 day simple moving average is $6.51 and its 200 day simple moving average is $5.98. NextPlat has a one year low of $3.38 and a one year high of $11.10. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.56 and a quick ratio of 2.12.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new position in shares of NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 1.30% of the company’s stock.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.